Taiwanese Pharmaceuticals & Biotech Top Dividend Payers

Syngen BiotechLtd

Market Cap: NT$2.1b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan and internationally.

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

TTY Biopharm

Market Cap: NT$19.3b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

Allied Biotech

Market Cap: NT$2.7b

Engages in the manufacture and sale of carotenoids worldwide.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Maxigen Biotech

Market Cap: NT$3.3b

Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.

Synmosa Biopharma

Market Cap: NT$15.9b

A specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally.

PharmaEngine

Market Cap: NT$7.8b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Bora Pharmaceuticals

Market Cap: NT$50.8b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.0b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.7b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

YungShin Global Holding

Market Cap: NT$14.9b

Through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics.

Formosa Laboratories

Market Cap: NT$5.4b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Sinphar PharmaceuticalLtd

Market Cap: NT$6.3b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.